Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

British Journal of Cancer (11)
Journal of Exposure Science and Environmental Epidemiology (4)
Bone Marrow Transplantation (3)
Nature Communications (2)
Prostate Cancer and Prostatic Diseases (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (23)
Advertorial (1)

Subject Check one or more subjects to show results from those subjects only.

Cancer
Chemical biology
Diseases
Evolution
Health care
Pathogenesis

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–24 of 24 results

Advanced filters: Author: J Kerger Clear advanced filters

Reverse dosimetry: interpreting trihalomethanes biomonitoring data using physiologically based pharmacokinetic modeling

Yu-Mei Tan
Kai H Liao
Harvey J Clewell III
Research15 Nov 2006
Journal of Exposure Science & Environmental Epidemiology

Volume: 17, P: 591-603
Phase I study on docetaxel and ifosfamide in patients with advanced solid tumours

LC Pronk
D Schrijvers
AT van Oosterom
Research01 Jan 1998
British Journal of Cancer

Volume: 77, P: 153-158
A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours

L C Pronk
P Vasey
C Twelves
ResearchOpen Access06 Jun 2000
British Journal of Cancer

Volume: 83, P: 22-29
Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin

Daniel H. Doherty
Michael P. Doyle
Douglas D. Lemon
Research01 Jul 1998
Nature Biotechnology

Volume: 16, P: 672-676
IL1R1⁺ cancer-associated fibroblasts drive tumor development and immunosuppression in colorectal cancer

IL1 signalling pathway has been shown to shape cancer associated fibroblast (CAF) heterogeneity. Here the authors identify a pro-tumorigenic CAF subtype in colorectal cancer characterized by high IL1R1 expression and associated with an immunosuppressive tumor microenvironment.

E. Koncina
M. Nurmik
E. Letellier
ResearchOpen Access17 Jul 2023
Nature Communications

Volume: 14, P: 1-17
Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer

Primary prostate tumours are known to be genetically heterogeneous and clonal selection has the potential to drive metastasis. Here Hong et al. show that the acquisition of TP53 mutations is linked to clonal expansion and metastatic progression to lethality.

Matthew K.H. Hong
Geoff Macintyre
Christopher M. Hovens
ResearchOpen Access01 Apr 2015
Nature Communications

Volume: 6, P: 1-12
Radiotherapy for genes that cause cancer

William H. Mcbride
Graeme J. Dougherty
Advertorial01 Nov 1995
Nature Medicine

Volume: 1, P: 1215-1217
Comparison of Trihalomethane exposure assessment metrics in epidemiologic analyses of reproductive and developmental outcomes

Thomas J. Luben
Rachel M. Shaffer
J. Michael Wright
Research14 Jun 2023
Journal of Exposure Science & Environmental Epidemiology

Volume: 34, P: 115-125
Peripheral neuropathy induced by combination chemotherapy of docetaxel and cisplatin

PHE Hilkens
LC Pronk
MJ van den Bent
Research01 Feb 1997
British Journal of Cancer

Volume: 75, P: 417-422
Docetaxel (Taxotere^TM) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group

A Sulkes
J Smyth
J Verweij
Research01 Aug 1994
British Journal of Cancer

Volume: 70, P: 380-383
Concurrent conventionally factionated radiotherapy and weekly docetaxel in the treatment of stage IIIb non-small-cell lung carcinoma

M I Koukourakis
N Bahlitzanakis
K Beroukas
ResearchOpen Access09 Jul 1999
British Journal of Cancer

Volume: 80, P: 1792-1796
Docetaxel (Taxotere^TM) is active in non-small-cell lung cancer: a phase II trial of the EORTC early clinical trials group (ECTG)

T Cerny
S Kaplan
S Kaye
Research01 Aug 1994
British Journal of Cancer

Volume: 70, P: 384-387
Management strategies for the hard-to-mobilize patient

Patrick J Stiff
Research01 Jun 1999
Bone Marrow Transplantation

Volume: 23, P: S29-S33
A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck

C Couteau
N Chouaki
J-P Armand
ResearchOpen Access10 Sept 1999
British Journal of Cancer

Volume: 81, P: 457-462
Sequential cycles of high-dose chemotherapy with dose escalation of carboplatin with or without paclitaxel supported by G-CSF mobilized peripheral blood progenitor cells: a phase I/II study in advanced ovarian cancer

H Wandt
J Birkmann
WM Gallmeier
Research19 Apr 1999
Bone Marrow Transplantation

Volume: 23, P: 763-770
High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancer

LA Holmberg
T Demirer
WI Bensinger
Research09 Oct 1998
Bone Marrow Transplantation

Volume: 22, P: 651-659
Docetaxel (Taxotere): an active agent in metastatic urothelial cancer; results of a phase II study in non-chemotherapy-pretreated patients

R de Wit
WHJ Kruit
J Verweij
Research01 Nov 1998
British Journal of Cancer

Volume: 78, P: 1342-1345
Cancer and renal insufficiency results of the BIRMA study

N Janus
V Launay-vacher
H Wildiers
ResearchOpen Access09 Nov 2010
British Journal of Cancer

Volume: 103, P: 1815-1821
Measurement of volatile organic compounds inside automobiles^†

Marion J Fedoruk
Brent D Kerger
Research01 Jan 2003
Journal of Exposure Science & Environmental Epidemiology

Volume: 13, P: 31-41
MSH2-deficient prostate tumours have a distinct immune response and clinical outcome compared to MSH2-deficient colorectal or endometrial cancer

Patrick McCoy
Stefano Mangiola
Christopher M. Hovens
Research09 Jun 2021
Prostate Cancer and Prostatic Diseases

Volume: 24, P: 1167-1180
Comparing nodal versus bony metastatic spread using tumour phylogenies

Stefano Mangiola
Matthew K. H. Hong
Christopher M. Hovens
ResearchOpen Access22 Sept 2016
Scientific Reports

Volume: 6, P: 1-10
Phase I study of Carzelesin (U-80,244) given (4-weekly) by intravenous bolus schedule

A Awada
C J A Punt
D J Th Wagener
ResearchOpen Access26 Feb 1999
British Journal of Cancer

Volume: 79, P: 1454-1461
Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study

A Roy
D Cunningham
J-L Misset
ResearchOpen Access05 Jul 2012
British Journal of Cancer

Volume: 107, P: 435-441
Ammonia exposure and hazard assessment for selected household cleaning product uses

Marion J Fedoruk
Rod Bronstein
Brent D Kerger
Research20 Jul 2005
Journal of Exposure Science & Environmental Epidemiology

Volume: 15, P: 534-544